Media
Careers
Investors
About
Leadership Team
Board of Directors
Advisory Board
Clinical Trials
About TIGeR-PaC
TIGeR-PaC
Candidate Criteria
TIGeR-PaC Participating
Clinical Sites
Our Therapy Platform
Pipeline Overview
Clinicians
Contact
About
Leadership Team
Board of Directors
Advisory Board
Clinical Trials
About TIGeR-PaC
TIGeR-PaC
Candidate Criteria
TIGeR-PaC Participating
Clinical Sites
Our Therapy Platform
Pipeline Overview
Clinicians
News
Careers
Investors
Contact
Investors
Investors
Overview
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
News & Events
Overview
Press Releases
Clinical News
IR Calendar Events
Email Alerts
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Filing Type:
View All
10-K
10-Q
3
3/A
4
424B3
424B4
424B5
8-A12B
8-K
CERT
CORRESP
D
DEF 14A
DRS
DRS/A
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2018
2016
2013
Date
Form
Description
PDF
XBRL
Pages
04/02/21
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
84
06/19/18
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
01/05/16
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
12/23/13
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
04/10/13
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Email Alerts
Contacts
RSS News Feed
Menu